PharmaCyte Biotech (PMCB) Earnings (2010 - 2026)
PharmaCyte Biotech (PMCB) earnings from Jul 31, 2010 to Jan 31, 2026. The TTM PharmaCyte Biotech (PMCB) earnings is -$3.28M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
PharmaCyte Biotech (PMCB) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -16.38% |
| 5 Years TTM | -0.36% |
| 10 Years TTM | -0.48% |
| All Time TTM | +3.65% |
Annual Earnings change of PharmaCyte Biotech (PMCB)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $750K | -97.55% |
| 2025 | $31M | +9190.91% |
| 2024 | $330K | -107.64% |
| 2023 | -$4.32M | +1.89% |
| 2022 | -$4.24M | +19.44% |
| 2021 | -$3.55M | -7.31% |
| 2020 | -$3.83M | -5.90% |
| 2019 | -$4.07M | -40.41% |
| 2018 | -$6.83M | +53.83% |
| 2017 | -$4.44M | -26.73% |
| 2016 | -$6.06M | +269.51% |
| 2015 | -$1.64M | -42.66% |
| 2014 | -$2.86M | -49.47% |
| 2013 | -$5.66M | +197.89% |
| 2012 | -$1.90M | +35.71% |
| 2011 | -$1.40M | +677.78% |
| 2010 | -$180K | N/A |
Comparison PharmaCyte Biotech (PMCB) five years earnings CAGR with competitors
PharmaCyte Biotech (PMCB) five years earnings CAGR is -0.36%.